title: Selective loss of lymphoid component simulating myeloma in lymphoplasmacytic lymphoma treated with rituximab.
authors.affiliation: Department of Histopathology, Nottingham City Hospital, Nottingham, UK. simonroconnor@gmail.com
authors.forename: Simon R
authors.initials: SR
authors.lastname: O'Connor
authors.forename: Shabeeha K
authors.initials: SK
authors.lastname: Rana
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000378:metabolism; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab